DD128133A5 - Verfahren zur herstellung neuer piperazinderivate - Google Patents

Verfahren zur herstellung neuer piperazinderivate

Info

Publication number
DD128133A5
DD128133A5 DD7700197240A DD19724077A DD128133A5 DD 128133 A5 DD128133 A5 DD 128133A5 DD 7700197240 A DD7700197240 A DD 7700197240A DD 19724077 A DD19724077 A DD 19724077A DD 128133 A5 DD128133 A5 DD 128133A5
Authority
DD
German Democratic Republic
Prior art keywords
piperazine derivatives
preparing new
new piperazine
preparing
derivatives
Prior art date
Application number
DD7700197240A
Other languages
German (de)
English (en)
Inventor
Richard Cyrus
Manfred Raschack
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of DD128133A5 publication Critical patent/DD128133A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
DD7700197240A 1976-02-07 1977-02-04 Verfahren zur herstellung neuer piperazinderivate DD128133A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
DD128133A5 true DD128133A5 (de) 1977-11-02

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700197240A DD128133A5 (de) 1976-02-07 1977-02-04 Verfahren zur herstellung neuer piperazinderivate

Country Status (25)

Country Link
US (1) US4079137A (xx)
JP (1) JPS52105186A (xx)
AT (1) AT355578B (xx)
AU (1) AU504526B2 (xx)
BE (1) BE850492A (xx)
CA (1) CA1094560A (xx)
CH (1) CH631448A5 (xx)
CS (1) CS201544B2 (xx)
DD (1) DD128133A5 (xx)
DE (1) DE2604845A1 (xx)
DK (1) DK138891C (xx)
ES (1) ES455691A1 (xx)
FI (1) FI63226C (xx)
FR (1) FR2340311A1 (xx)
GB (1) GB1550545A (xx)
HU (1) HU173483B (xx)
IE (1) IE44339B1 (xx)
IL (1) IL51316A (xx)
LU (1) LU76706A1 (xx)
NL (1) NL7700841A (xx)
NO (1) NO142625C (xx)
PL (1) PL105526B1 (xx)
PT (1) PT66154B (xx)
SE (1) SE7701187L (xx)
ZA (1) ZA77248B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
AU2005314271B2 (en) 2004-12-06 2011-06-16 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as cancer vaccine adjuvants
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
EP2240195A4 (en) * 2007-12-12 2011-12-21 Sciclone Pharmaceuticals Inc TREATMENT OF MELANOMA WITH ALPHA-THYMOSIN PEPTIDES IN ASSOCIATION WITH ANTIBODIES AGAINST ANTIGEN 4 ASSOCIATED WITH CYTOTOXIC LYMPHOCYTE T (CTLA4)
CA2708229A1 (en) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
EP2230908A1 (en) * 2007-12-14 2010-09-29 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
WO2010129947A2 (en) * 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
CN113855806A (zh) 2014-10-21 2021-12-31 赛生药品股份国际有限公司 用免疫刺激剂治疗癌症

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate

Also Published As

Publication number Publication date
CH631448A5 (de) 1982-08-13
DK138891C (da) 1979-04-23
DK138891B (da) 1978-11-13
IL51316A0 (en) 1977-03-31
DK49077A (da) 1977-08-08
DE2604845A1 (de) 1977-08-18
PL105526B1 (pl) 1979-10-31
BE850492A (fr) 1977-07-18
AU2195277A (en) 1978-08-10
IE44339B1 (en) 1981-10-21
PT66154B (fr) 1978-07-07
SE7701187L (sv) 1977-08-08
FI770398A (xx) 1977-08-08
ES455691A1 (es) 1978-01-01
NO142625B (no) 1980-06-09
LU76706A1 (xx) 1977-06-28
IE44339L (en) 1977-08-07
FR2340311B1 (xx) 1980-02-08
AU504526B2 (en) 1979-10-18
CS201544B2 (en) 1980-11-28
GB1550545A (en) 1979-08-15
HU173483B (hu) 1979-05-28
JPS52105186A (en) 1977-09-03
US4079137A (en) 1978-03-14
FI63226B (fi) 1983-01-31
CA1094560A (en) 1981-01-27
NO770374L (no) 1977-08-09
ZA77248B (en) 1977-11-30
FR2340311A1 (fr) 1977-09-02
PT66154A (fr) 1977-03-01
ATA68177A (de) 1979-08-15
IL51316A (en) 1980-12-31
AT355578B (de) 1980-03-10
NL7700841A (nl) 1977-08-09
NO142625C (no) 1980-09-17
FI63226C (fi) 1983-05-10

Similar Documents

Publication Publication Date Title
DD134642A5 (de) Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane
DD132869A5 (de) Verfahren zur herstellung neuer aminothiazolylazetamido-derivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
AT347476B (de) Verfahren zur herstellung neuer thiocarbamid- derivate
DD128133A5 (de) Verfahren zur herstellung neuer piperazinderivate
AT374806B (de) Verfahren zur herstellung neuer cephalosporinderivate
DD133949A5 (de) Verfahren zur herstellung neuer benzopyranderivate
AT352918B (de) Verfahren zur herstellung neuer histidin- derivate
AT367060B (de) Verfahren zur herstellung neuer cephalosporinderivate
DD131558A5 (de) Verfahren zur herstellung neuer indolizinderivate
ATA736576A (de) Verfahren zur herstellung neuer indolderivate
DD135390A5 (de) Verfahren zur herstellung neuer aryl-hexafuranoside
DD128270A5 (de) Verfahren zur herstellung neuer azofarbstoffe
LU79077A1 (de) Verfahren zur herstellung neuer benzothiopyranderivate
ATA173876A (de) Verfahren zur herstellung neuer 2,3-dihydro- benzofuranon-2-derivate
DD133331A5 (de) Verfahren zur herstellung neuer basischer substituierter theophyllinderivate
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
DD130047A5 (de) Verfahren zur herstellung neuer aminoglykosidaminozyklitolderivate
ATA111177A (de) Verfahren zur herstellung neuer thiazolinylbenzimidazolderivate
DD133799A1 (de) Verfahren zur herstellung neuer n-heterocyclisch substituierter adamantancarbonsaeureamide
DD138775A5 (de) Verfahren zur herstellung neuer pyranochinolinonderivate
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
AT372386B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
ATA947076A (de) Verfahren zur herstellung neuer ergolinderivate
ATA759479A (de) Verfahren zur herstellung neuer ergolinderivate